COVID-19-induced silent myocarditis and newly developed hypertension in a 3-year-old boy.

ABSTRACT:

Background

COVID-19 myocarditis occurs in 7-28% of patients admitted in the hospital with or without multisystem inflammatory syndrome. It may present as fulminant myocarditis. Dilated cardiomyopathy as a sequela of COVID-19 myocarditis has been reported in the pediatric population. However, to date, no case of silent COVID-19 myocarditis progressing to dilated cardiomyopathy has been reported in children. Furthermore, although newly developed hypertension as a sequela of COVID-19 infection has been reported in adults, there is no report of newly developed COVID-induced hypertension in children. We report a 3-year-old boy with silent COVID-19 myocarditis progressing to dilated cardiomyopathy and newly developed systemic hypertension.

Case presentation

A 3-year-old boy was re

SUBMITTER: Malakan Rad E 

PROVIDER: S-EPMC9152834 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature